[1] 梁雁,鲁云兰,车文玺.111 例药物性肝损害病例分析[J].药物不良反应杂志,2004,6(6):374-378. [2] 曾玲玲,周桂琴.药物性肝损害诊断标准及其临床应用[J].药物不良反应杂志,2011,13(1):20. [3] 朱欣欣,万朝敏.药物性肝损害研究进展[J].中国实用儿科杂志,2011,26(11):865-866. [4] HARTLEBM, BOERNATL,KOCHELA.Drug-induced liverdamage-a three-year study of patients from one gastroenterologicaldepartment[J].Med SciMonit, 2002, 8:CR292-296. [5] ANDRADE RJ, LUCENAMI, FERNANDEZMC, et a.l Drug-inducedliver injury: an analysis of 461 incidences submitted to the Spanishregistry over a 10-year period[J].Gastroenterology, 2005,129: 512-521. [6] MEIER Y, CAVALLARO M, ROOS M, et a.l Incidence of drugin-duced liver injury in medical inpatients[J].Eur J Clin Pharmaco,2005, 61:135-143. [7] 唐超,张学武.药物性肝病120 例回顾性分析[J].实用全科医学,2007,5(12):1059-1060. [8] 许建明.重视对药物肝毒性的临床监测[J].中华消化杂志,2004,24(8):449. [9] Jacobson T A. Comparat ive pharmacokinet ic int eracti on profiles of p ravast at in,simvas tat in, and at orvast atinwhen coadminister ed w it h cyt ochrome P450 inhibit ors[J].Am J Cardiol, 2004,94(9):1140-1146. [10] 李靖涛,朴云峰,孟祥伟.CYPIIE1基因多态性与药物性肝损害[J].中日友好医院学报,2002,16(2):67. [11] 韩硬海,李树桐.临床肝脏病学[M].山东科学技术出版社,2005:350-353. [12] 蔡晓频,李光伟.抗甲状腺药物与肝损害[J].国外医学内分泌学分册,2000,10(1):79. [13] 邓晓奇,蔡琳.抗凝治疗与转氨酶升高[J].心血管病学进展,2006,27(4):528. |